News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ALT market cap is 431.28M. The company's latest EPS is USD -1.1485 and P/E is -4.83.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 362k | 37k | 5k | 5k | 5k |
| Operating Income | -22.54M | -33.62M | -26.79M | -26.75M | -24.77M |
| Net Income | -20.67M | -31.64M | -24.39M | -24.64M | -22.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.8M | 8.19M | 4.41M | -68k | 426k |
| Operating Income | -20.47M | -54.8M | -85.92M | -87.74M | -95.93M |
| Net Income | -20.97M | -49.04M | -97.09M | -84.71M | -88.45M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 166.57M | 210.64M | 188.36M | 173.35M | 147.86M |
| Total Liabilities | 16.18M | 16.54M | 15.42M | 20.82M | 14.49M |
| Total Equity | 150.4M | 194.1M | 172.94M | 152.53M | 133.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.06M | 245.12M | 218.87M | 206.93M | 210.64M |
| Total Liabilities | 8.54M | 19.24M | 19.73M | 21.64M | 16.54M |
| Total Equity | 45.52M | 225.88M | 199.14M | 185.29M | 194.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -59.28M | -75.81M | -16.36M | -34.47M | -61.58M |
| Investing | 21.69M | 13.73M | -39.52M | -43.22M | -42.02M |
| Financing | 13.35M | 86.11M | -261k | -307k | -41k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.6M | -34.44M | -78.24M | -62.59M | -75.81M |
| Investing | -28.29M | -72.1M | 87.52M | -73.4M | 13.73M |
| Financing | 12.53M | 213.49M | 65.1M | 56.78M | 86.11M |
| Market Cap | 431.28M |
| Price to Earnings Ratio | -4.83 |
| Price to Sales Ratio | 1.01k |
| Price to Cash Ratio | 3.16 |
| Price to Book Ratio | 2.2 |
| Dividend Yield | - |
| Shares Outstanding | 77.01M |
| Average Volume (1 week) | 3.03M |
| Average Volume (1 Month) | 2.47M |
| 52 Week Change | -47.37% |
| 52 Week High | 11.50 |
| 52 Week Low | 5.29 |
| Spread (Intraday) | 1.67 (23.36%) |
| Company Name | Altimmune Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.altimmune.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
